105496-4
A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
Active
LOINC Names Get Info
- Fully-Specified Name
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%:
Find: Pt: ^Patient: Ord: - Long Common Name
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
- Short Name
- Not in the expected range of benefit
Part Model Get Info
- Component
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
LP441587-5
- Analyte
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
LP441587-5
- Component Numerator
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
LP441587-5
- Component Numerator Core
- A study of chemotherapy decreased the risk of dying from colon cancer by about 30%. and was 95% sure that the expected range of benefit was between 10% and 50%
LP441587-5
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- Find
LP6813-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- ^Patient
LP310005-6
- System Core
- NULL
- Super System
- Patient
LP6985-8
- Scale
- Ord
LP7751-3
- Method
- NULL
Survey Question
- PX280201110000
Example Answer List: LL6653-1
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| 11% decrease in risk | LA34245-3 | ||
| 30% decrease in risk | LA34246-1 | ||
| 45% decrease in risk | LA34247-9 | ||
| 95% decrease in risk | LA34248-7 |
Basic Attributes
- Class
- PHENX
- Type
- Clinical
- First Released
- Version 2.78
- Last Updated
- Version 2.83 (MIN)
- Order vs. Observation
- Observation
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 105506-0 | PhenX - health numeracy protocol 280201 |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| el-GR | Greek (Greece) | Μια μελέτη για τη χημειοθεραπεία μείωσε τον κίνδυνο θανάτου από καρκίνο του παχέος εντέρου κατά περίπου 30% και ήταν 95% βέβαιο ότι το αναμενόμενο εύρος οφέλους κυμαινόταν μεταξύ 10% και 50%.: Synonyms: - A Ord PHENX Pt Ασθενής Εύρεση Καρκίνος Κόλον Μελέτη Μια μελέτη για τη χημειοθεραπεία μείωσε τον κίνδυνο θανάτου από καρκίνο του παχέος εντέρου κατά περίπου 30% και ήταν 95% βέβαιο ότι το αναμενόμενο εύρος οφέλους κυμαινόταν μεταξύ 10% και 50%. Χημειοθεραπεία |
| it-IT | Italian (Italy) | Uno studio sulla chemioterapia ha ridotto il rischio di morte per cancro del colon di circa il 30%. ed era certo al 95% che l'intervallo di beneficio atteso fosse tra il 10% e il 50%: Synonyms: Osservazione paziente PhenX Punto nel tempo (episodio) |
| zh-CN | Chinese (China) | 研究表明化疗将死于结肠癌的风险降低了约 30%, Synonyms: A 型 Consensus measures for Phenotypes and eXposures; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://